📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy (2016)

First Author: Okkenhaug K

Attributed to: PIK signalling in Immunity and Infection funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-16-0716

PubMed Identifier: 27655435

Publication URI: http://europepmc.org/abstract/MED/27655435

Type: Journal Article/Review

Parent Publication: Cancer Discovery

Issue: 10

ISSN: 2159-8274